XML Sitemap

This is a XML Sitemap which is supposed to be processed by search engines which follow the XML Sitemap standard like Ask.com, Bing, Google and Yahoo.
It was generated using the WordPress content management system and the Google Sitemap Generator Plugin by Arne Brachhold.
You can find more information about XML sitemaps on sitemaps.org and Google's list of sitemap programs.

URLPriorityChange frequencyLast modified (GMT)
https://www.clinicaltrialsarena.com/news/newsdeals-this-week-akcea-therapeutics-inc-atara-biotherapeutics-inc-numab-therapeutics-ag-5774208/20%Daily2017-03-30 17:30
https://www.clinicaltrialsarena.com/news/newsakcea-begins-phase-iib-trial-of-akcea-apoa-lrx-for-high-lpa-cardiovascular-disease-5774900/20%Daily2019-08-09 08:29
https://www.clinicaltrialsarena.com/research-reports/researchreportreport-novel-drugs-for-unmet-needs-in-rheumatoid-arthritis-unlikely-before-2025-5775347/20%Daily2017-03-30 17:30
https://www.clinicaltrialsarena.com/news/newscbt-begins-enrollment-in-phase-i-trial-of-genolimzumab-to-treat-solid-tumours-in-australia-5775448/20%Daily2017-03-30 17:30
https://www.clinicaltrialsarena.com/comment/commenttype-2-diabetes-me-too-drugs-a-blessing-or-a-curse-5774936/20%Daily2017-03-30 07:50
https://www.clinicaltrialsarena.com/news/ensuring-greater-transparency-through-the-alltrials-campaign-5761500-2/20%Daily2018-07-18 13:06
https://www.clinicaltrialsarena.com/news/newsmillendo-commences-phase-ii-trial-of-atr-101-to-treat-endogenous-cs-5774348/20%Daily2017-03-29 17:30
https://www.clinicaltrialsarena.com/news/newsarmo-begins-dosing-in-phase-iii-trial-of-am0010-to-treat-pancreatic-cancer-5774369/20%Daily2017-03-29 17:30
https://www.clinicaltrialsarena.com/news/newsvertexs-tezacaftor-shows-positive-outcome-in-two-phase-iii-trials-to-treat-cf-5774511/20%Daily2017-03-29 17:30
https://www.clinicaltrialsarena.com/news/trial-results-create-a-win-for-patients-and-companies-5761498-2/20%Daily2018-08-15 13:16
https://www.clinicaltrialsarena.com/news/brexit-an-industry-perspective-5761417-2/20%Daily2018-07-18 13:21
https://www.clinicaltrialsarena.com/news/newsbiophytis-opens-sites-starts-enrollment-for-sara-obs-trial-of-sarconeos-in-europe-5773369/20%Daily2017-03-28 17:30
https://www.clinicaltrialsarena.com/news/newsinfectex-reports-positive-data-from-phase-iib-iii-trial-of-sq109-to-treat-mdr-tb-5773394/20%Daily2017-03-28 17:30
https://www.clinicaltrialsarena.com/comment/commentfourier-outcomes-data-highlights-the-importance-of-value-in-drug-development-5773865/20%Daily2017-03-28 17:30
https://www.clinicaltrialsarena.com/comment/commentunmet-needs-in-the-liver-cancer-market-mean-its-full-of-potential-5773045/20%Daily2017-03-28 03:37
https://www.clinicaltrialsarena.com/news/clinical-trial-results-in-numbers-why-opentrials-has-a-unique-appeal-5761469-2/20%Daily2018-07-18 13:09
https://www.clinicaltrialsarena.com/news/newsnewrons-nw-3509-meets-study-objectives-in-phase-iia-trial-to-treat-schizophrenia-5772686/20%Daily2017-03-27 17:30
https://www.clinicaltrialsarena.com/news/newserytech-reports-positive-results-from-phase-iib-trial-of-eryaspase-to-treat-pancreatic-cancer-5772697/20%Daily2017-03-27 17:30
https://www.clinicaltrialsarena.com/news/newsnektar-begins-dosing-in-phase-i-trial-of-nktr-358-to-treat-immune-inflammatory-disorders-5772974/20%Daily2017-03-27 17:30
https://www.clinicaltrialsarena.com/marketdata/researchreportrecent-failures-in-alzheimers-rd-5773097/20%Daily2017-03-27 17:30
https://www.clinicaltrialsarena.com/comment/commentfirst-in-class-opioid-analgesic-nktr-181-boasts-strong-phase-iii-results-5772128/20%Daily2017-03-27 05:05
https://www.clinicaltrialsarena.com/news/announcing-transparency-week-on-clinical-trials-arena-5761465-2/20%Daily2018-07-18 13:16
https://www.clinicaltrialsarena.com/news/newsctsa-programme-sites-sign-nihs-smart-agreement-for-single-irb-model-5771150/20%Daily2017-03-26 17:30
https://www.clinicaltrialsarena.com/news/newscancer-research-uk-invests-10m-in-new-project-for-pancreatic-cancer-trials-5771162/20%Daily2017-03-26 17:30
https://www.clinicaltrialsarena.com/news/newsneuren-reports-positive-top-line-results-from-phase-ii-trial-of-trofinetide-for-rett-syndrome-5771898/20%Daily2017-03-26 17:30
https://www.clinicaltrialsarena.com/news/keeping-pace-with-advancements-in-the-clinical-supply-chain-5761449-2/20%Daily2018-07-18 13:17
https://www.clinicaltrialsarena.com/comment/commentamgen-and-cytokinetics-approaching-acute-heart-failure-from-a-different-angle-5771116/20%Daily2017-03-24 06:15
https://www.clinicaltrialsarena.com/news/newsakashi-to-initiate-halo-dmd-04-trial-of-ht-100-to-treat-dmd-5769910/20%Daily2017-03-23 18:30
https://www.clinicaltrialsarena.com/news/newsmerrimacks-phase-i-trial-of-mm-310-starts-enrollment-for-solid-tumour-pateints-5770111/20%Daily2017-03-23 18:30
https://www.clinicaltrialsarena.com/news/newsdeals-this-week-heat-biologics-inc-bellicum-pharmaceuticals-inc-sutrovax-inc-5770612/20%Daily2017-03-23 18:30
https://www.clinicaltrialsarena.com/research-reports/researchreportreport-immune-thrombocytopenia-market-to-witness-minimal-growth-at-a-cagr-of-06-by-2025-5770872/20%Daily2017-03-23 18:30
https://www.clinicaltrialsarena.com/news/newsmas-this-week-zhejiang-jingxin-pharmaceutical-biolinerx-ltd-5770934/20%Daily2017-03-23 18:30
https://www.clinicaltrialsarena.com/news/newsengeneic-begins-dosing-in-phase-i-trial-of-edv-nanocells-to-treat-gbm-in-us-5768903/20%Daily2017-03-22 18:30
https://www.clinicaltrialsarena.com/news/newsintec-pharma-begins-phase-i-trial-of-ap-cbdthc-to-treat-low-back-pain-and-fibromyalgia-5769329/20%Daily2017-03-22 18:30
https://www.clinicaltrialsarena.com/news/newsgalapagos-begins-phase-i-trial-of-glpg0367-to-treat-cystic-fibrosis-5769626/20%Daily2017-03-22 18:30
https://www.clinicaltrialsarena.com/marketdata/researchreporttotal-prevalent-cases-of-dyslipidemia-expected-to-grow-globally-5770344/20%Daily2017-03-22 18:30
https://www.clinicaltrialsarena.com/news/will-a-focus-on-oncology-bring-blockbuster-success3-5761445-2/20%Daily2018-07-18 13:18
https://www.clinicaltrialsarena.com/news/newsblueprint-begins-dosing-in-phase-i-trial-of-blu-667-to-treat-solid-tumours-with-ret-5767883/20%Daily2017-03-21 18:30
https://www.clinicaltrialsarena.com/news/newsnovartis-new-trial-results-demonstrate-cosentyx-ability-to-modify-psoriasis-course-5768308/20%Daily2017-03-21 18:30
https://www.clinicaltrialsarena.com/news/newsapexigens-apx005m-combination-therapy-phase-iii-trial-for-melanoma-begins-enrollment-5768572/20%Daily2017-03-21 18:30
https://www.clinicaltrialsarena.com/comment/commentnew-class-of-diabetes-drugs-show-heart-failure-prevention-signal-5768237/20%Daily2017-03-21 10:26
https://www.clinicaltrialsarena.com/news/newsgalena-reports-positive-results-from-phase-iiia-trial-of-gale-301-to-prevent-cancer-recurrence-5766935/20%Daily2017-03-20 18:30
https://www.clinicaltrialsarena.com/news/newsergomed-begins-phase-ii-trial-of-peprostat-to-control-intraoperative-surgical-bleeding-5766941/20%Daily2017-03-20 18:30
https://www.clinicaltrialsarena.com/news/newsboehringer-ingelheim-begins-enrollment-in-phase-iii-trial-of-nintedanib-to-treat-pf-ild-5767471/20%Daily2017-03-20 18:30
https://www.clinicaltrialsarena.com/comment/commentare-anti-ageing-drugs-real-and-can-they-prevent-cancer-5767142/20%Daily2017-03-20 09:08
https://www.clinicaltrialsarena.com/comment/commentaurinia-poised-to-independently-commercialise-voclosporin-in-lupus-nephritis-5767138/20%Daily2017-03-20 09:00
https://www.clinicaltrialsarena.com/news/g-ba-early-advice-how-do-we-prepare-for-the-requirements-that-the-early-benefit-assessment-in-germany-poses-for-clinical-trials-5761431-2/20%Daily2018-07-18 13:20
https://www.clinicaltrialsarena.com/news/newspharnext-begins-phase-iii-extension-trial-of-pxt3003-to-treat-type-1a-cmt-5766445/20%Daily2017-03-19 18:30
https://www.clinicaltrialsarena.com/news/newsnordic-nanovector-begins-dosing-in-phase-i-trial-of-betalutin-for-dlbcl-5766513/20%Daily2017-03-19 18:30
https://www.clinicaltrialsarena.com/news/newsnightstarx-initiates-phase-iii-trial-of-aav-xlrpgr-therapy-to-treat-xlrp-5766597/20%Daily2017-03-19 18:30
https://www.clinicaltrialsarena.com/analysis/trump-fda-pick-considered-a-boost-for-the-industry-5766220-2/20%Daily2019-08-08 09:43
https://www.clinicaltrialsarena.com/news/newsdeals-this-week-amo-pharma-c4x-discovery-holdings-oncosec-medical-5764192/20%Daily2017-03-16 18:30
https://www.clinicaltrialsarena.com/news/newsbriacell-to-begin-phase-iiia-clinical-trial-of-briavax-to-treat-breast-cancer-5765116/20%Daily2017-03-16 18:30
https://www.clinicaltrialsarena.com/news/newsalkermes-starts-phase-iii-trial-of-alks-8700-to-treat-multiple-sclerosis-5765195/20%Daily2017-03-16 18:30
https://www.clinicaltrialsarena.com/news/newsmuk-phase-ib-trial-to-assess-reolysin-imnovidrevlimid-combination-to-treat-myeloma-5765208/20%Daily2017-03-16 18:30
https://www.clinicaltrialsarena.com/news/using-sap-technology-to-optimize-the-clinical-supply-chain-5761422-2/20%Daily2018-07-18 13:21
https://www.clinicaltrialsarena.com/news/newscelerion-deploys-vct-fingerprint-technology-at-clinical-trial-facilities-5763221/20%Daily2017-03-15 18:30
https://www.clinicaltrialsarena.com/news/newscatalyst-pharma-reports-positive-results-from-musk-mg-trial-of-firdapse-to-treat-mg-5763992/20%Daily2017-03-15 18:30
https://www.clinicaltrialsarena.com/news/newstrial-finds-antibody-drug-conjugate-immu-132-shrinks-triple-negative-breast-tumours-5764414/20%Daily2017-03-15 18:30
https://www.clinicaltrialsarena.com/news/newsamgen-reports-positive-top-line-results-from-phase-iii-trial-of-repatha-to-treat-ldl-c-5762267/20%Daily2017-03-14 18:30
https://www.clinicaltrialsarena.com/news/newslung-therapeutics-starts-phase-iab-trial-of-lti-01-for-pleural-effusions-in-australia-and-nz-5762468/20%Daily2017-03-14 18:30
https://www.clinicaltrialsarena.com/news/newsastrazenecas-lynparza-meets-primary-endpoint-in-phase-iii-trial-to-treat-ovarian-cancer-5763167/20%Daily2017-03-14 18:30
https://www.clinicaltrialsarena.com/news/higher-risk-of-opportunistic-infections-in-lupus-patients-highlights-the-need-for-improved-treatments-5761410-2/20%Daily2018-07-18 13:22
https://www.clinicaltrialsarena.com/news/newsgalapagos-to-investigate-filgotinib-in-two-phase-ii-trials-for-crohns-disease-5760651/20%Daily2017-03-13 18:30
https://www.clinicaltrialsarena.com/news/newszynerba-closes-enrollment-in-phase-ii-trials-of-zyn002-for-osteoarthritis-and-epilepsy-5761837/20%Daily2017-03-13 18:30
https://www.clinicaltrialsarena.com/news/newstransgene-begins-dosing-in-phase-ii-trial-of-tg4010-to-treat-nsclc-5761846/20%Daily2017-03-13 18:30
https://www.clinicaltrialsarena.com/news/newssensorion-to-start-phase-ii-trial-of-sens-111-to-treat-acute-vertigo-5760455/20%Daily2017-03-12 18:30
https://www.clinicaltrialsarena.com/news/newsbeigene-begins-dosing-in-phase-ii-trial-of-bgb-3111-for-cllsll-treatment-in-china-5760462/20%Daily2017-03-12 18:30
https://www.clinicaltrialsarena.com/news/2017-edition-of-oct-west-coast-draws-in-large-attendance-5759726-2/20%Daily2018-07-18 13:23
https://www.clinicaltrialsarena.com/news/newsbergenbio-merck-collaborate-for-bgb324-keytruda-evaluation-in-nsclc-and-tnbc-5759138/20%Daily2017-03-09 18:30
https://www.clinicaltrialsarena.com/news/newstigenix-reports-positive-topline-results-from-phase-iii-trial-of-cx601-for-perianal-fistulas-5759510/20%Daily2017-03-09 18:30
https://www.clinicaltrialsarena.com/news/newsdeals-this-week-spero-therapeutics-llc-biocryst-pharmaceuticals-inc-breath-therapeutics-holding-bv-5760114/20%Daily2017-03-09 18:30
https://www.clinicaltrialsarena.com/news/newsmas-this-week-pelican-therapeutics-inc-thru-pharma-llc-5760118/20%Daily2017-03-09 18:30
https://www.clinicaltrialsarena.com/news/newstyrogenex-closes-enrollment-in-phase-ii-trial-of-x-82-to-treat-wamd-5760225/20%Daily2017-03-09 18:30
https://www.clinicaltrialsarena.com/comment/commentptc-therapeutics-translarna-fails-phase-iii-trial-for-cystic-fibrosis-5759686/20%Daily2017-03-09 10:21
https://www.clinicaltrialsarena.com/news/exploring-sea-freight-as-a-viable-option-for-transporting-supplies-5757320-2/20%Daily2018-07-18 13:25
https://www.clinicaltrialsarena.com/news/newsst-georges-university-of-london-starts-trial-of-malaria-drug-artesunate-for-cancer-treatment-5758636/20%Daily2017-03-08 18:30
https://www.clinicaltrialsarena.com/news/newscelyad-to-begin-phase-ib-trial-of-nkr-2-car-t-to-treat-seven-cancer-indications-5758643/20%Daily2017-03-08 18:30
https://www.clinicaltrialsarena.com/news/newsmenlos-serlopitant-meets-endpoints-in-phase-ii-trial-for-prurigo-nodularis-patients-5758874/20%Daily2017-03-08 18:30
https://www.clinicaltrialsarena.com/news/arena-international-survey-reveals-current-and-future-trends-in-the-clinical-trial-supplies-market-5758435-2/20%Daily2018-07-18 13:24
https://www.clinicaltrialsarena.com/news/the-importance-of-seeing-the-whole-in-clinical-trials-5757310-2/20%Daily2018-07-18 13:26
https://www.clinicaltrialsarena.com/news/newsdeciphera-pharmaceuticals-starts-phase-i-trial-of-dcc-3014-for-advanced-malignancies-5757091/20%Daily2021-11-25 10:29
https://www.clinicaltrialsarena.com/news/newsimmunicum-begins-enrollment-in-phase-iii-trial-of-intuvax-to-treat-gist-5757845/20%Daily2017-03-07 18:30
https://www.clinicaltrialsarena.com/news/newsregenxbio-commences-dosing-in-phase-iii-trial-of-rgx-501-to-treat-hofh-5757863/20%Daily2017-03-07 18:30
https://www.clinicaltrialsarena.com/news/merck-co-weighs-in-on-pharma-pricing-debate-by-releasing-pricing-transparency-report2-5757400-2/20%Daily2018-07-18 13:25
https://www.clinicaltrialsarena.com/news/the-top-5-february-2017-5757271-2/20%Daily2018-07-18 13:27
https://www.clinicaltrialsarena.com/news/newsdaiichi-sankyo-begins-enrollment-in-phase-iiib-trial-of-edoxaban-to-treat-atrial-fibrillation-5756799/20%Daily2017-03-06 18:30
https://www.clinicaltrialsarena.com/news/newsmerck-reports-positive-data-from-phase-ib-trial-of-m1095-in-psoriasis-patients-5756985/20%Daily2017-03-06 18:30
https://www.clinicaltrialsarena.com/news/newschi-meds-phase-iii-cancer-trial-of-fruquintinib-meets-primary-endpoint-5756999/20%Daily2017-03-06 18:30
https://www.clinicaltrialsarena.com/analysis/featurefebruarys-top-stories-mercks-phase-iii-hiv-1-trial-results-nihs-phase-i-ags-v-vaccine-trial-5757057/20%Daily2017-03-06 18:30
https://www.clinicaltrialsarena.com/comment/commentpositive-results-from-the-long-term-extension-of-nemolizumab-in-atopic-dermatitis-5756297/20%Daily2019-08-07 13:57
https://www.clinicaltrialsarena.com/comment/commentencouraging-interim-safety-data-on-long-term-use-of-xeljanz-in-psoriatic-arthritis-5756295/20%Daily2017-03-06 10:20
https://www.clinicaltrialsarena.com/comment/commentjjs-guselkumab-leads-the-race-for-first-to-market-il-23-inhibitor-for-psoriasis-5756284/20%Daily2017-03-06 10:00
https://www.clinicaltrialsarena.com/comment/commentresults-from-ixora-s-show-superiority-of-taltz-to-stelara-in-psoriasis-5756281/20%Daily2017-03-06 09:55
https://www.clinicaltrialsarena.com/comment/commenttapinarof-poised-to-fill-a-void-in-psoriasis-treatment-5756276/20%Daily2017-03-06 09:50
https://www.clinicaltrialsarena.com/comment/commenta-new-age-of-drug-development-in-atopic-dermatitis-5756274/20%Daily2019-08-07 13:57
https://www.clinicaltrialsarena.com/comment/commentresults-from-phase-iib-trial-assessing-tralokinumab-for-the-treatment-of-moderate-to-severe-atopic-dermatitis-5756271/20%Daily2019-08-07 13:57
https://www.clinicaltrialsarena.com/comment/commentprimary-results-from-phase-iib-trial-assessing-olumacostat-glasaretil-for-acne-vulgaris-5756268/20%Daily2019-08-07 13:54
https://www.clinicaltrialsarena.com/comment/commenteucrisa-continues-to-show-promise-for-the-treatment-of-atopic-dermatitis-5756265/20%Daily2019-08-07 13:57
https://www.clinicaltrialsarena.com/news/newsbeigene-begins-dosing-in-phase-ii-trial-of-bgb-3111-to-treat-mcl-in-china-5755702/20%Daily2017-03-05 18:30
https://www.clinicaltrialsarena.com/news/newsjanssen-reports-positive-results-from-two-phase-iii-trials-of-guselkumab-in-plaque-psoriasis-5755711/20%Daily2017-03-05 18:30
https://www.clinicaltrialsarena.com/news/newscelgene-reports-positive-results-in-phase-iv-trial-of-otezla-to-treat-moderate-plaque-psoriasis-5755950/20%Daily2017-03-05 18:30
https://www.clinicaltrialsarena.com/news/the-implications-of-cold-chain-failure-5755057-2/20%Daily2018-07-18 13:28
https://www.clinicaltrialsarena.com/research-reports/researchreportreport-rheumatoid-arthritis-market-projected-to-reach-285bn-by-2025-5750078/20%Daily2017-03-02 18:30
https://www.clinicaltrialsarena.com/news/newsaudentes-begins-phase-iii-run-in-study-of-at342-to-treat-crigler-najjar-syndrome-5753834/20%Daily2017-03-02 18:30
https://www.clinicaltrialsarena.com/news/newsroche-reports-positive-results-from-phase-iii-trial-of-perjeta-combination-therapy-in-breast-cancer-5753906/20%Daily2017-03-02 18:30
https://www.clinicaltrialsarena.com/news/newsdeals-this-week-corbus-pharmaceuticals-holdings-inc-dermira-inc-vycellix-inc-5754251/20%Daily2017-03-02 18:30
https://www.clinicaltrialsarena.com/news/newsmas-this-week-genesis-biotechnology-group-llc-betta-pharmaceuticals-co-ltd-5754252/20%Daily2017-03-02 18:30
https://www.clinicaltrialsarena.com/news/epro-and-the-enave-5751481-2/20%Daily2018-07-18 13:29
https://www.clinicaltrialsarena.com/news/newsacceras-ac-1204-fails-to-show-positive-outcome-in-phase-iii-trial-for-alzheimers-5752475/20%Daily2017-03-01 18:30
https://www.clinicaltrialsarena.com/news/newsomeros-reports-positive-results-from-phase-ii-trial-of-oms721-in-thrombotic-microangiopathy-5752628/20%Daily2017-03-01 18:30
https://www.clinicaltrialsarena.com/news/newsmyovant-sciences-commences-phase-iii-trial-of-relugolix-to-treat-advanced-prostate-cancer-5753363/20%Daily2017-03-01 18:30
https://www.clinicaltrialsarena.com/marketdata/researchreportc-difficile-pipeline-vaccines-could-offer-an-alternative-to-antibiotics-5752720/20%Daily2017-03-01 09:33
https://www.clinicaltrialsarena.com/news/identify-weak-spots-and-anticipate-early-to-avoid-stock-outs-says-cts-expert-5751472-2/20%Daily2018-07-18 13:29